Clinical Trial Update: Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing pharmacokinetics and bioequivalence of Doxylamine+Pyridoxine (Diclectin) under fed conditions in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea

Drugs mentioned

• Diclectin (Doxylamine succinate and pyridoxine hydrochloride)
• Doxylamine+Pyridoxine (Doxylamine succinate and pyridoxine hydrochloride)

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Nausea | Phase 1 | Status: COMPLETED